• EyePoint will hold fireside chats at Guggenheim’s Healthcare Innovation Conference Nov. 9, 2026, and Stifel’s Healthcare Conference Nov. 10, 2026.
• Further fireside chats are scheduled at Jefferies’ London healthcare conference Nov. 16, 2026, and UBS’ biopharma conference Nov. 17, 2026.
• Eyenovate at FLORetina presentations Dec. 3, 2026, will cover LUCIA Phase 3 results and updates on COMO/CAPRI Phase 3 trials.
• FLORetina-ICOOR Congress presentations Dec. 4-5, 2026, will address EYP-1901, including LUCIA efficacy and safety results and COMO/CAPRI trial overviews.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. EyePoint Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611060700PRIMZONEFULLFEED9872002) on November 06, 2026, and is solely responsible for the information contained therein.